These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 21763448)

  • 1. Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).
    Tai HH; Chi X; Tong M
    Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):37-40. PubMed ID: 21763448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells.
    Chi X; Freeman BM; Tong M; Zhao Y; Tai HH
    Arch Biochem Biophys; 2009 Jul; 487(2):139-45. PubMed ID: 19501039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
    Fink SP; Dawson DM; Zhang Y; Kresak A; Lawrence EG; Yang P; Chen Y; Barnholtz-Sloan JS; Willis JE; Kopelovich L; Markowitz SD
    Carcinogenesis; 2015 Feb; 36(2):291-8. PubMed ID: 25503930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-Hydroxyprostaglandin-dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs COX-1 inhibitors on a human medullary thyroid carcinoma cell line.
    Quidville V; Segond N; Lausson S; Frenkian M; Cohen R; Jullienne A
    Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):14-30. PubMed ID: 16997128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase.
    Wakimoto N; Wolf I; Yin D; O'Kelly J; Akagi T; Abramovitz L; Black KL; Tai HH; Koeffler HP
    Cancer Res; 2008 Sep; 68(17):6978-86. PubMed ID: 18757412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indomethacin, a cox inhibitor, enhances 15-PGDH and decreases human tumoral C cells proliferation.
    Frenkian M; Segond N; Pidoux E; Cohen R; Jullienne A
    Prostaglandins Other Lipid Mediat; 2001 May; 65(1):11-20. PubMed ID: 11352223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1.
    Moon Y; Bottone FG; McEntee MF; Eling TE
    Mol Cancer Ther; 2005 Oct; 4(10):1551-8. PubMed ID: 16227405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells.
    Mehdawi LM; Satapathy SR; Gustafsson A; Lundholm K; Alvarado-Kristensson M; Sjölander A
    Oncotarget; 2017 May; 8(21):35033-35047. PubMed ID: 28402256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cyclooxygenase inhibitor indomethacin modulates gene expression and represses the extracellular matrix protein laminin gamma1 in human glioblastoma cells.
    Ishibashi M; Bottone FG; Taniura S; Kamitani H; Watanabe T; Eling TE
    Exp Cell Res; 2005 Jan; 302(2):244-52. PubMed ID: 15561105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase/LTB(4) dehydrogenase.
    Clish CB; Sun YP; Serhan CN
    Biochem Biophys Res Commun; 2001 Nov; 288(4):868-74. PubMed ID: 11688989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin catabolic enzymes as tumor suppressors.
    Tai HH
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):409-17. PubMed ID: 22020925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents.
    Cho H; Tai HH
    Prostaglandins Leukot Essent Fatty Acids; 2002 Dec; 67(6):461-5. PubMed ID: 12468268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-4 up-regulates 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in human lung cancer cells.
    Chi X; Tai HH
    Exp Cell Res; 2010 Aug; 316(14):2251-9. PubMed ID: 20632471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers.
    Yan M; Rerko RM; Platzer P; Dawson D; Willis J; Tong M; Lawrence E; Lutterbaugh J; Lu S; Willson JK; Luo G; Hensold J; Tai HH; Wilson K; Markowitz SD
    Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17468-73. PubMed ID: 15574495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.
    Tong M; Ding Y; Tai HH
    Carcinogenesis; 2006 Nov; 27(11):2170-9. PubMed ID: 16632868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-canonical WNT5A signaling up-regulates the expression of the tumor suppressor 15-PGDH and induces differentiation of colon cancer cells.
    Mehdawi LM; Prasad CP; Ehrnström R; Andersson T; Sjölander A
    Mol Oncol; 2016 Nov; 10(9):1415-1429. PubMed ID: 27522468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
    Thiel A; Ganesan A; Mrena J; Junnila S; Nykänen A; Hemmes A; Tai HH; Monni O; Kokkola A; Haglund C; Petrova TV; Ristimäki A
    Clin Cancer Res; 2009 Jul; 15(14):4572-80. PubMed ID: 19584167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors.
    Richter M; Weiss M; Weinberger I; Fürstenberger G; Marian B
    Carcinogenesis; 2001 Jan; 22(1):17-25. PubMed ID: 11159736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.
    Castro-Sánchez L; Agra N; Llorente Izquierdo C; Motiño O; Casado M; Boscá L; Martín-Sanz P
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2501-11. PubMed ID: 23954207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.